FI971037A - Framställnig av multivesiculära liposomer för kontrollerad frigöring av aktiva substanser - Google Patents

Framställnig av multivesiculära liposomer för kontrollerad frigöring av aktiva substanser Download PDF

Info

Publication number
FI971037A
FI971037A FI971037A FI971037A FI971037A FI 971037 A FI971037 A FI 971037A FI 971037 A FI971037 A FI 971037A FI 971037 A FI971037 A FI 971037A FI 971037 A FI971037 A FI 971037A
Authority
FI
Finland
Prior art keywords
preparation
controlled release
active substances
multivesicular liposomes
multivesicular
Prior art date
Application number
FI971037A
Other languages
English (en)
Finnish (fi)
Other versions
FI119621B (sv
FI971037A0 (sv
Inventor
Mantripragada B Sankaram
Sinil Kim
Original Assignee
Depotech Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Depotech Corp filed Critical Depotech Corp
Publication of FI971037A0 publication Critical patent/FI971037A0/sv
Publication of FI971037A publication Critical patent/FI971037A/sv
Application granted granted Critical
Publication of FI119621B publication Critical patent/FI119621B/sv

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Liposomes
    • A61K9/1277—Processes for preparing; Proliposomes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Liposomes
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/829—Liposomes, e.g. encapsulation
FI971037A 1994-09-13 1997-03-12 Framställnig av multivesiculära liposomer för kontrollerad frigöring av aktiva substanser FI119621B (sv)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US08/305,158 US5993850A (en) 1994-09-13 1994-09-13 Preparation of multivesicular liposomes for controlled release of encapsulated biologically active substances
US30515894 1994-09-13
PCT/US1995/011609 WO1996008235A1 (en) 1994-09-13 1995-09-13 Preparation of multivesicular liposomes for controlled release of active agents
US9511609 1995-09-13

Publications (3)

Publication Number Publication Date
FI971037A0 FI971037A0 (sv) 1997-03-12
FI971037A true FI971037A (sv) 1997-05-12
FI119621B FI119621B (sv) 2009-01-30

Family

ID=23179585

Family Applications (1)

Application Number Title Priority Date Filing Date
FI971037A FI119621B (sv) 1994-09-13 1997-03-12 Framställnig av multivesiculära liposomer för kontrollerad frigöring av aktiva substanser

Country Status (14)

Country Link
US (1) US5993850A (sv)
EP (1) EP0781123B1 (sv)
JP (1) JP3026271B2 (sv)
KR (1) KR100387561B1 (sv)
CN (1) CN1096850C (sv)
AU (1) AU697484B2 (sv)
BR (1) BR9508913A (sv)
CA (1) CA2199004C (sv)
DE (1) DE69535297T2 (sv)
FI (1) FI119621B (sv)
MX (1) MX9701856A (sv)
NO (1) NO323581B1 (sv)
NZ (2) NZ334561A (sv)
WO (1) WO1996008235A1 (sv)

Families Citing this family (73)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6558952B1 (en) * 1992-12-14 2003-05-06 Waratah Pharmaceuticals, Inc. Treatment for diabetes
US5931809A (en) * 1995-07-14 1999-08-03 Depotech Corporation Epidural administration of therapeutic compounds with sustained rate of release
US5997899A (en) * 1996-10-01 1999-12-07 Skyepharma Inc. Method for producing liposomes with increased percent of compound encapsulated
US5891467A (en) * 1997-01-31 1999-04-06 Depotech Corporation Method for utilizing neutral lipids to modify in vivo release from multivesicular liposomes
KR19980067138A (ko) * 1997-01-31 1998-10-15 박원훈 유전자 또는 생물학적 활성 약물을 세포내로 효과적으로 전달하는 지방 유제 및 그것의 제조방법
US6106858A (en) * 1997-09-08 2000-08-22 Skyepharma, Inc. Modulation of drug loading in multivescular liposomes
US6306432B1 (en) * 1997-09-08 2001-10-23 Chiron Corporation High and low load formulations of IGF-I in multivesicular liposomes
EP2198854B1 (en) 1997-09-18 2011-11-30 Pacira Pharmaceuticals, Inc. Sustained-release liposomal anesthetic compositions
US20020039596A1 (en) * 1997-11-14 2002-04-04 Hartoun Hartounian Production of multivesicular liposomes
CA2338031C (en) * 1998-07-17 2006-12-05 Sankaram Bhima Mantripragada Biodegradable compositions for the controlled release of encapsulated substances
US20040037818A1 (en) * 1998-07-30 2004-02-26 Brand Stephen J. Treatment for diabetes
US20030059440A1 (en) * 1998-09-01 2003-03-27 Tim Clarot Composition and method for moisturizing nasal tissue
US6740643B2 (en) * 1999-01-21 2004-05-25 Mirus Corporation Compositions and methods for drug delivery using amphiphile binding molecules
CA2365847A1 (en) * 1999-04-06 2000-10-12 Gregg M. Duthaler Methods for producing droplets for use in capsule-based electrophoretic displays
AUPQ259399A0 (en) 1999-09-01 1999-09-23 Lustre Investments Pte Ltd Therapeutic agents
US6812217B2 (en) 2000-12-04 2004-11-02 Medtronic, Inc. Medical device and methods of use
US6897196B1 (en) * 2001-02-07 2005-05-24 The Regents Of The University Of California pH sensitive lipids based on ortho ester linkers, composition and method
DE10109897A1 (de) * 2001-02-21 2002-11-07 Novosom Ag Fakultativ kationische Liposomen und Verwendung dieser
US20050156340A1 (en) 2004-01-20 2005-07-21 E Ink Corporation Preparation of capsules
ATE373466T1 (de) * 2001-11-13 2007-10-15 Celator Pharmaceuticals Inc Lipidträgerzusammensetzungen und verfahren zur verbesserten wirkstoffzurückhaltung
US20040082521A1 (en) * 2002-03-29 2004-04-29 Azaya Therapeutics Inc. Novel formulations of digitalis glycosides for treating cell-proliferative and other diseases
KR20050037508A (ko) * 2002-05-24 2005-04-22 와라타 파마수티컬즈, 인크. 당뇨병의 치료
US6998051B2 (en) * 2002-07-03 2006-02-14 Ferro Corporation Particles from supercritical fluid extraction of emulsion
US6966990B2 (en) 2002-10-11 2005-11-22 Ferro Corporation Composite particles and method for preparing
US20040229810A1 (en) * 2002-10-22 2004-11-18 Antonio Cruz Gastrin compositions and formulations, and methods of use and preparation
CA2501677A1 (en) * 2002-10-22 2004-05-06 Waratah Pharmaceuticals, Inc. Treatment of diabetes
EP3427742B1 (en) * 2002-10-29 2020-08-12 Insmed Incorporated Liposomes comprising an aminoglycoside for the treatment of pulmonary infections
US7718189B2 (en) 2002-10-29 2010-05-18 Transave, Inc. Sustained release of antiinfectives
JP2006508126A (ja) * 2002-11-06 2006-03-09 アザヤ セラピューティクス インコーポレイティッド 薬学的製剤のタンパク質安定化されたリポソーム製剤
US7083748B2 (en) * 2003-02-07 2006-08-01 Ferro Corporation Method and apparatus for continuous particle production using supercritical fluid
US20060008531A1 (en) * 2003-05-08 2006-01-12 Ferro Corporation Method for producing solid-lipid composite drug particles
US7416756B2 (en) 2003-09-10 2008-08-26 Eastman Chemical Company Process for the recovery of a phytolipid composition
CN1315530C (zh) * 2005-07-04 2007-05-16 重庆大学 蛋白质类药物控制释放系统制备方法
US20070110674A1 (en) * 2005-07-29 2007-05-17 Yuhong Xu Sono-active liposomes and lipid particles and use thereof as contrast agents and active-agent delivery systems
CA2631872C (en) 2005-12-08 2014-04-01 Transave, Inc. Lipid-based compositions of antiinfectives for treating pulmonary infections and methods of use thereof
CN101190183B (zh) * 2006-11-29 2010-05-12 上海医药工业研究院 一种盐酸可乐定多泡脂质体及其制备方法
US20100196455A1 (en) * 2007-05-04 2010-08-05 Transave, Inc. Compositions of Multicationic Drugs for Reducing Interactions with Polyanionic Biomolecules and Methods of Use Thereof
US9114081B2 (en) 2007-05-07 2015-08-25 Insmed Incorporated Methods of treating pulmonary disorders with liposomal amikacin formulations
US9119783B2 (en) 2007-05-07 2015-09-01 Insmed Incorporated Method of treating pulmonary disorders with liposomal amikacin formulations
US9333214B2 (en) 2007-05-07 2016-05-10 Insmed Incorporated Method for treating pulmonary disorders with liposomal amikacin formulations
US20100102142A1 (en) * 2008-10-28 2010-04-29 Daria Tagliareni Scent dispenser assembly
CN101756902B (zh) * 2008-12-23 2011-10-05 上海医药工业研究院 一种可乐定多囊脂质体及其制备方法
EP2813220A3 (en) 2010-04-09 2015-06-17 Pacira Pharmaceuticals, Inc. Method for formulating large diameter synthetic membrane vesicles
EP2394640A1 (en) 2010-05-21 2011-12-14 MediGene AG Improved liposomal formulations of lipophilic compounds
BR112013000244A2 (pt) 2010-07-06 2016-05-17 Novartis Ag lipossomas com lipídeos apresentando pka vantajoso para administração de rna
SI2591114T1 (sl) 2010-07-06 2016-10-28 Glaxosmithkline Biologicals S.A. Imunizacija velikih sesalcev z majhnimi odmerki RNA
LT3243526T (lt) 2010-07-06 2020-02-10 Glaxosmithkline Biologicals S.A. Rnr pristatymas, skirtas keleto imuninio atsako paleidimui
SI3970742T1 (sl) 2010-08-31 2022-08-31 Glaxosmithkline Biologicals S.A. Pegilirani liposomi za dostavo RNA, ki kodira imunogen
EP3520813B1 (en) 2010-10-11 2023-04-19 GlaxoSmithKline Biologicals S.A. Antigen delivery platforms
WO2012058483A1 (en) * 2010-10-28 2012-05-03 Pacira Pharmaceuticals, Inc. A sustained release formulation of a non-steroidal anti-inflammatory drug
EP2672958A1 (en) * 2011-02-08 2013-12-18 Halozyme, Inc. Composition and lipid formulation of a hyaluronan-degrading enzyme and the use thereof for treatment of benign prostatic hyperplasia
WO2012135010A2 (en) * 2011-03-25 2012-10-04 Selecta Biosciences, Inc. Osmotic mediated release synthetic nanocarriers
CA2840989A1 (en) 2011-07-06 2013-01-10 Novartis Ag Immunogenic combination compositions and uses thereof
JP2015500241A (ja) * 2011-12-02 2015-01-05 ペガサス ラボラトリーズ インコーポレイテッド 両親媒性脂質をベースとする徐放性組成物
US10722458B2 (en) 2011-12-02 2020-07-28 Pegasus Laboratories, Inc. Amphipathic lipid-based sustained release compositions
EP2846772A4 (en) 2012-05-10 2015-12-30 Painreform Ltd DEPOT FORMULATIONS OF A HYDROPHOBIC ACTIVE SUBSTANCE AND METHOD FOR THE PRODUCTION THEREOF
WO2013177226A1 (en) 2012-05-21 2013-11-28 Insmed Incorporated Systems for treating pulmonary infections
CN102764456B (zh) * 2012-07-24 2014-10-15 上海交通大学 血管栓塞剂及其用途、制备方法
CA2891487A1 (en) 2012-11-29 2014-06-05 Insmed Incorporated Stabilized vancomycin formulations
FR3008900B1 (fr) * 2013-07-25 2018-03-30 Centre Nat Rech Scient Nanoparticules lipidiques multicompartimentees
LT3466432T (lt) 2014-05-15 2020-12-28 Insmed Incorporated Būdai, skirti plaučių netuberkuliozinėms mikobakterinėms infekcijoms gydyti
JP6316182B2 (ja) * 2014-12-19 2018-04-25 富士フイルム株式会社 リポソームの製造方法及びリポソーム製造装置
WO2017078009A1 (ja) * 2015-11-02 2017-05-11 富士フイルム株式会社 リポソーム組成物およびその製造方法
EP3541815A4 (en) 2016-11-18 2020-07-15 Pacira Pharmaceuticals, Inc. ZINC MELXICAM COMPLEX MICROPARTICLE MULTIVESICULAR LIPOSOME FORMULATIONS AND METHODS OF MAKING THE SAME
KR102069670B1 (ko) * 2017-03-02 2020-01-23 단디바이오사이언스 주식회사 면역활성물질을 포함하는 다중도메인캡슐, 이의 제조방법, 및 이를 포함하는 면역조절 조성물
CN106924185B (zh) * 2017-03-29 2019-11-26 烟台大学 一种载有囊泡的多囊脂质体的制备方法
EP3773505A4 (en) 2018-03-30 2021-12-22 Insmed Incorporated PROCESS FOR THE CONTINUOUS MANUFACTURING OF LIPOSOMAL MEDICINAL PRODUCTS
KR102186704B1 (ko) * 2019-02-18 2020-12-04 (주)아이엠디팜 서방성 지질 전구 제제 및 이를 포함하는 지질 용액 형태의 서방성 주사용 약학 조성물
US11033495B1 (en) 2021-01-22 2021-06-15 Pacira Pharmaceuticals, Inc. Manufacturing of bupivacaine multivesicular liposomes
US11357727B1 (en) 2021-01-22 2022-06-14 Pacira Pharmaceuticals, Inc. Manufacturing of bupivacaine multivesicular liposomes
US11278494B1 (en) 2021-01-22 2022-03-22 Pacira Pharmaceuticals, Inc. Manufacturing of bupivacaine multivesicular liposomes
CN113509440B (zh) * 2021-03-26 2022-08-30 中国药科大学 一种高包封率酮咯酸多囊脂质体制备及提高其稳定性方法
CN113171343A (zh) * 2021-05-14 2021-07-27 成都大学 一种局部注射用硫酸阿米卡星多囊脂质体及其制备方法

Family Cites Families (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH588887A5 (sv) * 1974-07-19 1977-06-15 Battelle Memorial Institute
US4897308A (en) * 1975-06-30 1990-01-30 L'oreal Compositions comprising aqueous dispersions of lipid spheres
US4078052A (en) * 1976-06-30 1978-03-07 The United States Of America As Represented By The Secretary Of Health, Education And Welfare Large unilamellar vesicles (LUV) and method of preparing same
US4086257A (en) * 1976-10-12 1978-04-25 Sears Barry D Phosphatidyl quaternary ammonium compounds
CH624011A5 (sv) * 1977-08-05 1981-07-15 Battelle Memorial Institute
US4235871A (en) * 1978-02-24 1980-11-25 Papahadjopoulos Demetrios P Method of encapsulating biologically active materials in lipid vesicles
US4310506A (en) * 1979-02-22 1982-01-12 California Institute Of Technology Means of preparation and applications of liposomes containing high concentrations of entrapped ionic species
JPS55153713A (en) * 1979-05-02 1980-11-29 Kureha Chem Ind Co Ltd Pharmaceutical preparation of ribosome containing active substance
US4394372A (en) * 1980-12-22 1983-07-19 The Procter & Gamble Company Process for making lipid membrane structures
US4522803A (en) * 1983-02-04 1985-06-11 The Liposome Company, Inc. Stable plurilamellar vesicles, their preparation and use
US4588578A (en) * 1983-08-08 1986-05-13 The Liposome Company, Inc. Lipid vesicles prepared in a monophase
US4599227A (en) * 1983-11-07 1986-07-08 Wisconsin Alumni Research Foundation Injectable pharmaceutical preparation for the induction of multiple follicular growth
JPS60118666A (ja) * 1983-11-30 1985-06-26 太陽誘電株式会社 誘電体磁器組成物
US5077056A (en) * 1984-08-08 1991-12-31 The Liposome Company, Inc. Encapsulation of antineoplastic agents in liposomes
IE58981B1 (en) * 1985-10-15 1993-12-15 Vestar Inc Anthracycline antineoplastic agents encapsulated in phospholipid micellular particles
US5204112A (en) * 1986-06-16 1993-04-20 The Liposome Company, Inc. Induction of asymmetry in vesicles
US4781871A (en) * 1986-09-18 1988-11-01 Liposome Technology, Inc. High-concentration liposome processing method
US4752425A (en) * 1986-09-18 1988-06-21 Liposome Technology, Inc. High-encapsulation liposome processing method
US4920016A (en) * 1986-12-24 1990-04-24 Linear Technology, Inc. Liposomes with enhanced circulation time
GB8704171D0 (en) * 1987-02-23 1987-04-01 Clayton Found Res Multivesicular liposomes
JP2666345B2 (ja) * 1987-04-16 1997-10-22 武田薬品工業株式会社 リポソーム製剤およびその製造法
DE68901733T2 (de) * 1988-03-04 1993-03-25 Takeda Chemical Industries Ltd Liposom-zusammensetzung.
US5576017A (en) * 1988-05-30 1996-11-19 Depotech Corporation Heterovesicular liposomes
US5422120A (en) * 1988-05-30 1995-06-06 Depotech Corporation Heterovesicular liposomes
BE1001869A3 (fr) * 1988-10-12 1990-04-03 Franz Legros Procede d'encapsulation liposomiale d'antibiotiques aminoglucosidiques, en particulier de la gentamycine.
DK0729351T3 (da) * 1993-11-16 2000-10-16 Skyepharma Inc Vesikler med reguleret afgivelse af aktivstoffer
US5766627A (en) * 1993-11-16 1998-06-16 Depotech Multivescular liposomes with controlled release of encapsulated biologically active substances

Also Published As

Publication number Publication date
AU697484B2 (en) 1998-10-08
NO323581B1 (no) 2007-06-11
BR9508913A (pt) 1997-12-30
EP0781123A1 (en) 1997-07-02
WO1996008235A1 (en) 1996-03-21
AU3511595A (en) 1996-03-29
CN1096850C (zh) 2002-12-25
JPH10502667A (ja) 1998-03-10
EP0781123A4 (en) 2000-12-20
MX9701856A (es) 1998-07-31
CA2199004C (en) 2008-02-19
FI119621B (sv) 2009-01-30
NO971149L (no) 1997-05-13
EP0781123B1 (en) 2006-11-15
JP3026271B2 (ja) 2000-03-27
NZ334561A (en) 2000-01-28
NZ292830A (en) 1999-04-29
KR100387561B1 (ko) 2003-10-08
CA2199004A1 (en) 1996-03-21
DE69535297D1 (de) 2006-12-28
FI971037A0 (sv) 1997-03-12
US5993850A (en) 1999-11-30
CN1166136A (zh) 1997-11-26
NO971149D0 (no) 1997-03-12
DE69535297T2 (de) 2007-05-16

Similar Documents

Publication Publication Date Title
FI971037A0 (sv) Framställnig av multivesiculära liposomer för kontrollerad frigöring av aktiva substanser
NO973250D0 (no) Preparater for avlevering av antigener
NO973938L (no) Farmasöytisk preparat av piperidinoalkanolforbindelser
HK1001860A1 (en) I-phenyl-2-dimethylaminomethyl-cyclohexan-1-ol compounds as pharmaceutical active ingredients
ZA965866B (en) 6-Dimethylaminomethyl-1-phenyl-cyclohexane compounds as pharmaceutical active ingredients
FI932655A (fi) Imidatderivat av farmaceutiskt anvaendbara antikonvulsiva sulfamat
NO20021111D0 (no) Anvendelse av 5-O-deoaminyl-6-O-metylerytronolid A-derivater for fremstilling av biologisk aktive produkter
ZA988718B (en) Drug formulation having controlled release of active compound
IL124768A0 (en) Novel pyridine compounds processes for their preparation and their use as pharmaceutical agents
FI97944B (sv) Anordning för avgivande av verksamt ämne
NO964915D0 (no) Transdermal avlevering av antiepileptiske legemidler
FI964229A0 (sv) Förfarande för framställning av doxorubicin
ZA968230B (en) Administration of biologically active material
NO932860D0 (no) Fremgangsmaate for fremstilling av kalsium-l-askorbat-2-fosfat
NO963871D0 (no) Kombinasjoner av aktive insektisidforbindelser
PL323828A1 (en) Mixtures of fungicidal active substances
AU4314993A (en) Mixtures of active anti-microbial substances
FI956058A (sv) Förfarande för framställning av glutardialdehyd
PL323592A1 (en) Fungicidal combinations of active substances
FI972694A0 (sv) Nytt förfarande för framställning av sameridin
FI932786A0 (sv) Anordning för avgivande av verksamt ämne
FI971964A0 (sv) Förfarande för framställning av 1-halo-3-trialkylsilanylbensenderivat
FI933872A (fi) Foerfarande foer framstaellning av terapeutiskt anvaendbara 1,3,4-bensotriazepin-5(4H)-on-derivat
FI98443B (sv) Maskin för stränginplastning av storbalar med såväl runt som rektangulärt tvärsnitt
SI0859595T1 (en) Therapeutic preparation for the transdermal administration of active substances